Cell-Based Immunotherapies

New for 2020, The Cell-Based Immunotherapy stream focuses on the latest protein engineering, clinical and analytical strategies driving the development of cell-based immunotherapies such as CAR Ts, TCRs, TILs and NKs, for the treatment of cancer and immune disorders. Topics include improving target identification, optimizing product design, specificity, safety, characterization and analytics.

Conferences Include:

August 31 - September 1

Improving Immunotherapy Efficacy and Safety

September 2-3

CAR Ts, TCRs and TILs

September 3-4

Cell and Gene Therapy Analytics


Keynote Speakers:

 

Prasad Adusumilli, MD, FACS, FCCP Deputy Chief and Associate Attending, Thoracic Surgery; Director, Mesothelioma


Adrian Bot, PhD Vice President, Translational Medicine, Kite Pharma, a Gilead Company


Jan Joseph (Jos) Melenhorst, PhD Adjunct Associate Professor, Pathology & Laboratory Medicine, University of Pennsylvania


Jeffrey Miller, MD Professor of Medicine, Deputy Director, Masonic Cancer Center, Division of Hematology, Oncology and Transplantation, University of Minnesota


Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag


View By: